
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
MOST MIDLIFE AND OLDER ADULTS TAKE PRESCRIPTION DRUGS AND CONTINUE TO BE CONCERNED ABOUT AFFORDING THEM. Most (82 percent) adults 50 and older report taking prescription medication
regularly, with the majority (81 percent) reporting that they did not skip filling a prescription due to cost. Yet, roughly six in ten (59 percent) say they are concerned about their ability
to afford prescription drugs in the next few years. When it comes to political affiliation, however, Democrats and Independents are more likely to say they are concerned that they may not
be able to afford the cost of prescription medications they or a family member may need in the next few years (62 percent of Democrats and 68 percent of Independents vs. 53 percent of
Republicans register concern). They are also more likely to say they are extremely or very concerned that the high cost of prescription drugs could negatively impact their health or the
health of someone in their household (32 percent of Democrats and 42 percent of Independents vs. 24 percent of Republicans). NEARLY ALL WOULD LIKE TO SEE GOVERNMENTAL ACTION TO ADDRESS
PRESCRIPTION DRUG COSTS, WITH LIMITED VARIATION BY POLITICAL AFFILIATION. Nearly all adults (96 percent) 50 and older believe it is important for the government to do more to lower
prescription drug prices. Similarly, nearly all (94 percent) consider it important for the newly elected Congress and incoming Trump administration to prioritize lowering prescription drug
costs. Democrats are more likely than both Republicans and Independents to say it is extremely important (63 percent vs. 28 percent of Republicans and 44 percent of Independents). Notably,
Republicans also consider it important for the government to do more to lower prescription drug prices, albeit with a lower stated intensity than their counterparts — they are more likely
than Democrats to say it is very (42 percent vs. 30 percent) or somewhat important (24 percent vs. 6 percent) to do so. Similarly, when considering the importance of lowering prescription
drug prices by the new Congress and the Trump administration, Democrats are more likely than both Republicans and Independents to say it is extremely important (59 percent vs. 24 percent of
Republicans and 45 percent of Independents). Republicans again show a lower stated intensity than their counterparts, with roughly four in ten (39 percent) Republicans saying that it is very
important compared to one-quarter of Independents (25 percent) and three in ten (29 percent) Democrats who say so. When asked to select their top priority (among three) for Congress to
address in the next year, nearly half (46 percent) of U.S. adults 50 and older say they would like Congress to address lowering prescription drug prices in the next year, while an identical
percentage (46 percent) would prefer it focus on funding the federal government for the full year. Notably, there are no significant differences by political affiliation. PROTECTING
MEDICARE’S ABILITY TO NEGOTIATE FOR LOWER PRESCRIPTION DRUG PRICES IS ALSO CONSIDERED VITAL, AGAIN WITH LIMITED VARIATION BY POLITICAL AFFILIATION. U.S. adults 50 and older overwhelmingly
believe (97 percent) it is important for Congress and the administration to protect Medicare’s ability to negotiate for lower prescription drug prices. As with the other questions about
governmental action, Democrats are more likely than both Independents and Republicans to say it is extremely important to protect Medicare’s ability to negotiate for lower prescription drug
prices (70 percent of Democrats vs. 48 percent of Independents and 37 percent of Republicans). Republicans are more likely than either Independents or Democrats to say that it is very
important (42 percent vs. 22 percent and 24 percent). METHODOLOGY These findings are based on a survey conducted in December 2024 to learn more about the views of midlife and older adults on
the costs of prescription drugs and what they would like Congress and the incoming Trump administration to do to address them. The sample of 1,016 Americans 50 and older was based on data
weighted to the latest Current Population Survey (CPS) benchmarks developed by the U.S. Census Bureau and are balanced by gender, age, education, race/ethnicity, and region. The final
weighted data reflect the U.S. population of adults 50 and over. The study was conducted using the NORC Foresight 50+ Panel among a sample of U.S. adults 50 and older using a combination of
phone and online sampling. The survey interviews averaged six minutes in length. The interviews were conducted in English December 12–16, 2024. For more information, please contact Teresa A.
Keenan at [email protected]. For media inquiries, please contact External Relations at [email protected].